|
|
ICEID
2002 Webcast
Invited Panels
Sunday,
March 24 |
Keynote
Session |
- Peter
Drotman, CDC, Atlanta, GA
- Jeffrey
Koplan, Director, CDC, Atlanta, GA
- James
Hughes, Director, National Center for Infectious Diseases,
CDC, Atlanta, GA
- Gail
Cassell, Eli Lilly and Company, Indianapolis, IN
- Patty
Stonesifer, Executive Director, Bill and Melinda Gates
Foundation, Seattle, WA
|
|
|
Monday,
March 25
Panel Sessions at 1:00 - 2:30 PM |
Zoonotic
Diseases Panel |
- Surveillance
of Livestock for Zoonotic Diseases and Veterinary Bio-Threat
Agents
William D. Hueston, College of Veterinary Medicine, University
of Minnesota, St. Paul, MN
- The
Emergence of Infectious Diseases Among Wildlife and the
Origin of Human Zoonoses
Peter Daszak, Consortium for Conservation Medicine, Palisades,
NY
- Shared
Animal and Human Influenza Viruses: a Role in the Next Pandemic?
Kennedy F. Shortridge, University of Hong Kong, Queen Mary
Hospital, Hong Kong
- Preventing
Human Disease by Controlling Pathogen Transmission in the
Animal Reservoir
Charles E. Rupprecht, CDC, Atlanta, GA
|
Innovative
Surveillance Systems Panel |
- Syndromic
Surveillance in a Managed Care Setting
Richard Platt, Ambulatory Care and Prevention, Harvard Medical
School, Boston, MA
- BT
Surveillance in NYC
Farzad Mostashari, Bureau of Communicable Disease, New York
City Dept of Health, New York, NY
- CD
Electronic surveillance in the UK and EU
Michael Catchpole, PHLS Communicable Disease Surveillance
Centre, London, England
- PulseNet
and Beyond
Balasubra Swaminathan, CDC, Atlanta, GA
|
Foodborne/Waterborne
Disease Panel |
- Public
Health and Policy Implications of the Recent Large Drinking
Water Outbreaks in Canada
Andrea Ellis, Center for Infectious Diseases Prevention
and Control Guelph, Ontario, Canada
- The
Risk of Food and Water Contamination from Animal Manure
Christine Moe, Rollins School of Public Health, Emory University,
Atlanta, GA
- Food
Safety: Perceived Risk and Public Trust
Carol Tucker Foreman, Consumer Federation of America, Washington,
DC
|
Disease
Eradication Panel |
- Overveiw
Walter Dowdle, Task Force for Child Survival and Development;
Atlanta, GA
- Eradication
of Dracunculiasis
Ernesto Ruiz-Tiben, CDC, Atlanta, GA
- Eradication
of Lymphatic Filariasis and Onchocerciasis
Eric Ottesen, Lymphatic Filariasis Support Center, Rollins
School of Public Health, Emory University, Atlanta GA
- Eradication
of Chagas Disease
Gabriel Schmunis, Pan American Health Organization,
Washington, DC
- Eradication
of T. solium Cysticercosis
Peter Schantz, CDC, Atlanta, GA
|
Public
Health Policy/Law Panel |
- Foodborne
Disease
Leslie Kux, U.S. Food and Drug Administration, Rockville,
MD
- Bioterrorism
Richard Hoffman, University of Colorado Health Sciences
Center, Denver, CO
- West
Nile Virus Outbreak
Wilfredo Lopez, New York City Department of Health, New
York, NY
- Gobal
Health and International Regulations
David Fidler, School of Law, Indiana University, Bloomington,
IN
|
|
|
Tuesday,
March 26
Panel Sessions at 1:00 - 2:30 PM |
Preventing
Infectious Disease Through Behavioral Change Panel |
- The
Essential Role of Behavior and Social Sciences in the Prevention
of Emerging Infectious Diseases
Emily Zielinski-Gutiérrez, CDC, Fort Collins, CO
- Bringing
Dengue Prevention Down to Earth: Evaluation of a Head Start
Project in Puerto Rico
Carmen L. Pérez Guerra, CDC, San Juan, PR
- Increasing
Water Vessel Use in Kenya
Philip S. Makutsa, CARE International in Kenya, Homa Bay,
Kenya
- Sex
Workers as Targets of and Agents for HIV/STI Prevention
Rafael Mazin, Pan American Health Organization HCA/HCP,
Washington, DC
|
Pathogen
Discovery Panel |
- Clusters
of Clinical Syndromes in Patients with Unexplained Encephalitis
Carol Glaser, California Department of Health Services,
Berkeley, CA
- Proteomics
and Pathogen Discovery
Donald Hunt, University of Virginia, Charlottesville, VA
- The
New Human Metapneumovirus
Albert Osterhaus, Erasmus University of Rotterdam, Rotterdam,
The Netherlands
- Multiple
Array Technology To Look for mRNA Patterns Associated with
Disease and Pathogens
David A. Relman, Stanford University, Stanford, CA
|
Emerging
Issues in Healthcare Settings Panel |
- Controlling
Antimicrobial Resistance
Barry Farr, University of Virginia Hospital, Charlottesville,
VA
- Prevention of Intravascular Catheter-Related Infections
Leonard Mermel, Rhode Island Hospital, Providence, RI
- Patient
Safety: Applying Industrial Quality Models in Healthcare
Settings To Improve Outcomes
Julie Gerberding, CDC, Atlanta, GA
- The
Role of Healthcare Systems in Bioterrorism Preparedness
Trish Perl, Johns Hopkins Hospital, Baltimore, MD
|
The
World and Its Moving Parts: An Overview
|
- The
World and Its Moving Parts: An Overview
Martin Cetron, CDC, Atlanta
- Global
Migration and Emerging Infectious Diseases
Daniele Grondin, International Organization for Migration, Geneva, Switzerland
- The Globalization of Our Food Supply: Implications for Emerging
Infections
Michael Osterholm, University of Minnesota Academic Health
Center, Minneapolis, MN
- Emerging
Vectorborne Disease: The Case of Yellow Fever
C.J. Peters, University of Texas, Medical Branch, Galveston,
TX
|
Anthrax
2001: Lessons that Stunned Us Panel |
- Inhalation Anthrax in Florida
Steve Wiersma, Florida Department of Health, Tallahassee,
FL
- Cutaneous Anthrax in New York City
Marcelle Layton, New York Department of Health, New York,
NY
- Anthrax in the U.S. Postal System
Michele L. Pearson, CDC, Atlanta, GA
- Inhalation Anthrax of Unknown Source
James L. Hadler, Connecticut Department of Public Health,
Hartford, CT
|
|
|
Wednesday,
March 27
Panel Sessions at 10:30 - 12:00 PM |
Anatomy
of Emerging Infectious Diseases |
- Impact
of the BSE/vCJD Outbreak: U.S. Concerns for TSEs
Ermias Belay, CDC, Atlanta, GA
- The
Agent: Prions as Emerging Infectious Particles
David Bolton, New York State Institute for
Basic Research, Staten Island, NY
- The
Reservoir: Bovine Spongiform Encephalopathy and What's Been
Done About It
Dagmar Heim, Swiss Federal Veterinary Office,
Bern-Liebefeld, Switzerland
- The
Unfolding Variant (vCJD) Epidemic
Robert Will, Western General Hospital, Edinburgh,
United Kingdom
|
Antimicrobial
Resistance |
- Computerized
Decision Support for Appropriate Antimicrobial Drug Prescribing
Matthew Samore, University of Utah, Salt
Lake City, UT
- Implications
of Gene Transfer and Inducible Resistance for Successful
Therapy
Abigail Salyers, American Society for Microbiology,
Washington, DC
- Promoting
Appropriate Antimicrobial Drug Use in Developing Countries
Sayomporn Sirinavin, Mahidol University,
Bangkok, Thailand
- Prospects
for New Antimicrobial Drug Development: Industry Perspective
Gail Cassell, Eli Lilly and Company, Indianapolis,
IN
|
Emerging
Vaccines for Emerging Diseases |
- Anthrax
Vaccines
Arthur Friedlander, U.S. Army Medical Research
Institute of Infectious Diseases, Fort Detrick, MD
- Group
B Meningococcal Vaccines
Gustavo Sierra, Finlay Institute, Havana,
Cuba
- New
Technologies and Vaccine Development
Margaret Ann Liu, Bill and Melinda Gates
Foundation, Seattle, WA
- Rotavirus
Vaccines in Development
Rajiv Bahn, All India Institute of Medical
Sciences, New Delhi, India
|
Foreign
Policy and Infectious Disease |
- Emerging
Infectious Diseases: The World Bank Perspective
O.K. Pannenborg, The World Bank, Washington,
DC
- Global Fund to Fight HIV/AIDS, TB, and Malaria (New Political/Economic
Model for Addressing Priority Infectious Diseases)
Bill Steiger, U.S. Department of Health
and Human Services, Washington DC
- Infectious
Diseases and U.S. Foreign Policy from a State Deptartment
Perspective
Jack Chow, U.S. Department of State, Washington,
DC
|
Infectious
Diseases in Aging Populations |
- Biology
of Aging
Steven Castle, University of California
at Los Angeles, Los Angeles, CA
- Biology
of Immune Senescence
Richard Miller, University of Michigan,
Ann Arbor, MI
- HIV
in the Older Patient
Bradley Bender, University of Florida, Gainesville,
FL
- Impact
of Aging on the Epidemiology of Infections in Adults
Thomas Yoshikawa, Charles R. Drew University
of Medicine and Science, Los Angeles, CA
|
|
|